Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
I Gede Putu Supadmanaba, Giulia Mantini, Ornella Randazzo, Mjriam Capula, Ittai B. Muller, Stella Cascioferro, Patrizia Diana, Godefridus J. Peters & Elisa Giovannetti. (2022) Interrelationship between miRNA and splicing factors in pancreatic ductal adenocarcinoma. Epigenetics 17:4, pages 381-404.
Read now
Read now
Maliheh Safavi, Reyhaneh Sabourian & Mohammad Abdollahi. (2016) The development of biomarkers to reduce attrition rate in drug discovery focused on oncology and central nervous system. Expert Opinion on Drug Discovery 11:10, pages 939-956.
Read now
Read now
Articles from other publishers (18)
Matthew T. Peller & Koushik K. Das. (2023) Blood-Based Biomarkers in the Diagnosis and Risk Stratification of Pancreatic Cysts. Gastrointestinal Endoscopy Clinics of North America 33:3, pages 559-581.
Crossref
Crossref
Christian Prinz, Leonard Fehring & Robin Frese. (2022) MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions. Cells 11:15, pages 2374.
Crossref
Crossref
Nilgun Gurbuz, Nermin Kahraman, Hafize Elif Sonmez, Hamada Ahmed Mokhlis, Pinar Aslan Kosar & Bulent Ozpolat. (2022) miRNA-193b-5p Suppresses Pancreatic Cancer Cell Proliferation, Invasion, Epithelial
Mesenchymal Transition, and Tumor Growth by Inhibiting eEF2K. Anti-Cancer Agents in Medicinal Chemistry 22:14, pages 2607-2618.
Crossref
Crossref
Nihad Boukrout, Mouloud Souidi, Fatima Lahdaoui, Belinda Duchêne, Bernadette Neve, Lucie Coppin, Emmanuelle Leteurtre, Jérôme Torrisani, Isabelle Van Seuningen & Nicolas Jonckheere. (2021) Antagonistic Roles of the Tumor Suppressor miR-210-3p and Oncomucin MUC4 Forming a Negative Feedback Loop in Pancreatic Adenocarcinoma. Cancers 13:24, pages 6197.
Crossref
Crossref
Yi-Fan Xu, Xiaohui Xu, Kritisha Bhandari, Amy Gin, Chinthalapally V. Rao, Katherine T. Morris, Bethany N. Hannafon & Wei-Qun Ding. (2021) Isolation of extra-cellular vesicles in the context of pancreatic adenocarcinomas: Addition of one stringent filtration step improves recovery of specific microRNAs. PLOS ONE 16:11, pages e0259563.
Crossref
Crossref
Maria Mortoglou, Zoey Kathleen Tabin, E. Damla Arisan, Hemant M Kocher & Pinar Uysal-Onganer. (2021) Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy. Translational Oncology 14:7, pages 101090.
Crossref
Crossref
Md. Hafiz Uddin, Mohammed Najeeb Al-Hallak, Philip A. Philip, Ramzi M. Mohammad, Nerissa Viola, Kay-Uwe Wagner & Asfar S. Azmi. (2021) Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside. Cancers 13:11, pages 2777.
Crossref
Crossref
Taotao Qian, Shunbin Shi, Lincen Xie & Yong Zhu. (2019) miR‐938 promotes cell proliferation by regulating RBM5 in lung adenocarcinoma cells. Cell Biology International 44:1, pages 295-305.
Crossref
Crossref
Xiaohong Jiang, Dongxia Hou, Zhe Wei, Shasha Zheng, Yujing Zhang & Jing Li. (2019) Extracellular and intracellular microRNAs in pancreatic cancer: from early diagnosis to reducing chemoresistance. ExRNA 1:1.
Crossref
Crossref
Takuma Goto, Mikihiro Fujiya, Hiroaki Konishi, Junpei Sasajima, Shugo Fujibayashi, Akihiro Hayashi, Tatsuya Utsumi, Hiroki Sato, Takuya Iwama, Masami Ijiri, Aki Sakatani, Kazuyuki Tanaka, Yoshiki Nomura, Nobuhiro Ueno, Shin Kashima, Kentaro Moriichi, Yusuke Mizukami, Yutaka Kohgo & Toshikatsu Okumura. (2018) An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker. BMC Cancer 18:1.
Crossref
Crossref
Gang Chen, Ming Hu, Xiusheng Qu, Kaifeng Wang & Yikun Qu. (2018) MicroRNA‑584 directly targets CCND1 and inhibits cell proliferation and invasion in pancreatic cancer. Molecular Medicine Reports.
Crossref
Crossref
Lumir Kunovsky, Pavla Tesarikova, Zdenek Kala, Radek Kroupa, Petr Kysela, Jiri Dolina & Jan Trna. (2018) The Use of Biomarkers in Early Diagnostics of Pancreatic Cancer. Canadian Journal of Gastroenterology and Hepatology 2018, pages 1-10.
Crossref
Crossref
Lunshou Wei, Kunhou Yao, Shibao Gan & Zhimin Suo. (2018) Clinical utilization of serum- or plasma-based miRNAs as early detection biomarkers for pancreatic cancer. Medicine 97:35, pages e12132.
Crossref
Crossref
Qing Cheng, Li-Hua Han, Hai-Juan Zhao, Hui Li & Jian-Bing Li. (2017) Abnormal alterations of miR-1 and miR-214 are associated with clinicopathological features and prognosis of patients with PDAC. Oncology Letters 14:4, pages 4605-4612.
Crossref
Crossref
Yi-Fan Xu, Bethany N. Hannafon, Yan D. Zhao, Russell G. Postier & Wei-Qun Ding. (2017) Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer. Oncotarget 8:44, pages 77028-77040.
Crossref
Crossref
Kai Qu, Xing Zhang, Ting Lin, Tian Liu, Zhixin Wang, Sushun Liu, Lei Zhou, Jichao Wei, Hulin Chang, Ke Li, Zheng Wang, Chang Liu & Zheng Wu. (2017) Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation. Scientific Reports 7:1.
Crossref
Crossref
Christina Vorvis, Marina Koutsioumpa & Dimitrios Iliopoulos. (2016) Developments in miRNA gene signaling pathways in pancreatic cancer. Future Oncology 12:9, pages 1135-1150.
Crossref
Crossref
Deng-Rui LiuQuan-Lin GuanMing-Tai GaoLei JiangHong-Xia Kang. (2016) miR-1260b is a Potential Prognostic Biomarker in Colorectal Cancer. Medical Science Monitor 22, pages 2417-2423.
Crossref
Crossref